학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 124건 | 목록 1~20
Academic Journal
Hearing Balance and Communication. 19:327-331
Academic Journal
Mantia CM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Jegede OA; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.; McDermott DF; Department of Medicine, Harvard Medical School, Boston, MA.; Dana-Farber Harvard Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA.; Heng DYC; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, AB, Canada.; Xie W; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Regan MM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE
Academic Journal
Ikhapoh I; Department of Medical Science, Harvard Medical School, Boston, MA 02115, USA.; Department of Medical Microbiology and Immunology, Creighton School of Medicine, Omaha, NE 68178, USA.; Atairu U; Corcoran School of the Arts and Design, The George Washington University, Washington, DC 20006, USA.; Reich AJ; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA 02120, USA.; Mantia CM; Department of Medical Science, Harvard Medical School, Boston, MA 02115, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Wei XX; Department of Medical Science, Harvard Medical School, Boston, MA 02115, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Sekar R; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.; Clinton TN; Department of Urology, Brigham and Women Hospital, Jamaica Plain, MA 02130, USA.; Mossanen M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Urology, Brigham and Women Hospital, Jamaica Plain, MA 02130, USA.
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
Academic Journal
Mantia CM; Harvard Medical School, Boston, Massachussetts, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Jegede OA; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Plimack ER; Department of Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania, USA.; Powles T; Department of Urology, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free National Health Service Trust, London, UK.; Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Lee CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Tomita Y; Department of Urology, Department of Molecular Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Voss MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Choueiri TK; Harvard Medical School, Boston, Massachussetts, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Rini BI; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.; Hammers HJ; Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Escudier B; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Albigès L; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Rosenblatt L; Bristol Myers Squibb, Princeton, New Jersey, USA.; Atkins MB; Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Regan MM; Harvard Medical School, Boston, Massachussetts, USA mregan@jimmy.harvard.edu.; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; McDermott DF; Harvard Medical School, Boston, Massachussetts, USA.; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center, Boston, Massachusetts, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
McGregor BA; Dana Farber Cancer Institute, Harvard Medical School, Boston. Electronic address: Bradley_mcgregor@dfci.harvard.edu.; Sonpavde GP; Dana Farber Cancer Institute, Harvard Medical School, Boston; Advent Health Cancer Institute and the University of Central Florida, Orlando.; Kwak L; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Regan MM; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Gao X; Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Hvidsten H; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Mantia CM; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Wei XX; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Berchuck JE; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Berg SA; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Ravi PK; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Michaelson MD; Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Choueiri TK; Dana Farber Cancer Institute, Harvard Medical School, Boston.; Bellmunt J; Dana Farber Cancer Institute, Harvard Medical School, Boston. Electronic address: Joaquim_Bellmunt@dfci.harvard.edu.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Mantia CM; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; McDermott DF; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Mantia CM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sonpavde G; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Academic Journal
Mantia CM; Department of Medical Oncology, Dana-Farber Cancer Institute.; Department of Medicine, Harvard Medical School.; Werner L; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Stwalley B; Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey.; Ritchings C; Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey.; Tarhini AA; Department of Cutaneous Oncology and Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, Florida.; Atkins MB; Department of Medical Oncology, Georgetown Lombardi Comprehensive Cancer Center.; Department of Medicine, Georgetown University School of Medicine, Washington, DC.; McDermott DF; Department of Medicine, Harvard Medical School.; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Regan MM; Department of Medicine, Harvard Medical School.; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE
Academic Journal
Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts. mregan@jimmy.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Jegede OA; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mantia CM; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free National Health Service Trust, London, United Kingdom.; Werner L; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Tannir NM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Lee CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Tomita Y; Department of Urology, Niigata University, Niigata, Japan.; Voss MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Plimack ER; Division of Genitourinary Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Choueiri TK; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rini BI; Vanderbilt Ingram Cancer Center, Nashville, Tennessee.; Hammers HJ; Division of Hematology and Oncology, UT Southwestern, Dallas, Texas.; Escudier B; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Albiges L; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Huo S; Worldwide Health Economics and Outcomes Research-US Market, Bristol Myers Squibb, Princeton, New Jersey.; Del Tejo V; US Medical Oncology, Bristol Myers Squibb, Princeton, New Jersey.; Stwalley B; Worldwide Health Economics and Outcomes Research-US Market, Bristol Myers Squibb, Princeton, New Jersey.; Atkins MB; Division of Hematology/Oncology, Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia.; McDermott DF; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Regan MM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA mregan@jimmy.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.; Mantia CM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Werner L; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Tarhini AA; H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Larkin J; The Royal Marsden NHS Foundation Trust, London, UK.; Stephen Hodi F; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Wolchok J; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Cornell Medical College, New York, New York, USA.; Postow MA; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Cornell Medical College, New York, New York, USA.; Stwalley B; Bristol Myers Squibb, Princeton, New Jersey, USA.; Moshyk A; Bristol Myers Squibb, Princeton, New Jersey, USA.; Ritchings C; Bristol Myers Squibb, Princeton, New Jersey, USA.; Re S; Bristol Myers Squibb, Princeton, New Jersey, USA.; van Dijck W; Bristol Myers Squibb, Braine-l'Alleud, Belgium.; McDermott DF; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Mantia CM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어